Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
353 Leser
Artikel bewerten:
(2)

ABO Capital CEO Zandre Campos Discusses African Entrepreneurship on CNBC Africa

Finanznachrichten News

Global entrepreneur shares his optimism for Africa's startup funding rebound, citing increased privatization and geographic advantages

NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Zandre Campos, CEO of ABO Capital, an international investment firm that builds opportunities in emerging markets across Africa, appeared on CNBC Africa on Monday, August 12, 2024, to discuss the future of African entrepreneurship and state of investment.

Joining CNBC Africa's Power Lunch West Africa program, Campos spoke with host Wole Famurewa about the reasons for optimism regarding African entrepreneurship, despite this year's downturn in startup funding. Campos shared his belief in the youth of Africa, emphasizing the critical need to prioritize expanding access to education and technology for future generations of entrepreneurs.

"The youth of Africa will not continue waiting for this moment. I think this is the moment of Africa. Even though it's difficult, this is what we see on the investment side and from the improvements we are making in Africa," said Campos. "The baseline for development in Africa and investment in Africa is education. There is a huge field for education, and this is the base for the success of other investments."

In addition, Campos discussed the promising future for startups in sectors like tourism, agriculture and manufacturing. Campos also expounded on the opportunities for startup investment outside of Africa's "big four" - Kenya, Nigeria, South Africa, and Egypt - noting the strategic advantages of emerging markets like Angola that make it primed for continued growth.

"I think there are a lot of opportunities, not only geographically speaking - geopolitically speaking - but culturally speaking," said Campos. "Most of the countries [in Africa] have a base of English, we in Angola have a base of Portuguese, so you can tackle different parts of the world. You can tackle Europe, you can tackle the Spanish side of the world. [Angola] has 1,550 kilometers of coast, huge amounts of arable land - and we think we have a very bright future."

Campos' appearance on CNBC Africa follows ABO Capital's ongoing investments in Africa's young people and future innovators. The firm recently opened the Amity Training Center in Luanda and hosted esteemed NYU professor Yaw Nyarko for a masterclass on the new digital financial era. To watch the full interview, visit CNBC Africa.

About ABO Capital

ABO Capital is an international investment firm that builds opportunities in emerging markets across Africa. Led by global entrepreneur Zandre Campos, ABO Capital invests in companies that create value and promote economic development throughout Africa. With a focus on education and technology, ABO Capital also operates in the financial services, energy, manufacturing, distribution and real estate sectors. ABO Capital is headquartered in Angola with offices in Dubai and the United States. Learn more at abocapital.net.

About Zandre Campos

Zandre Campos is one of the great, innovative business leaders and global entrepreneurs emerging out of Africa. Currently, he is chairman and CEO of ABO Capital, an international investment firm that builds opportunities in emerging markets across Africa. Campos was named one of the Top 25 African business influencers and was a recipient of the Distinguished Business Excellence Award by African Leadership Magazine and the Africa Award by CEO Magazine. An advocate for bringing better education and technology to Africa, Campos is frequently quoted as an expert on Africa in the media and has spoken at leading industry conferences around the world.

Media Contact

Christina Levin
Caliber Corporate Advisers
christina@calibercorporateadvisers.com

SOURCE: ABO Capital




View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.